The FTC Continues to Focus on Competitors Sharing Company Directors in Violation of Section 8 of the Clayton Act
The Federal Trade Commission announced today that three individuals have resigned from their positions on the Board of Directors of Sevita Health (Sevita) in response to the Federal Trade Commission’s enforcement of the Clayton Act, which generally prohibits directors and officers from serving simultaneously on the boards of competitors.